GlobeNewsWire
08 Apr 2026, 13:31 UTC · 28w ago
From Genetic Puzzle to Industrial Platform
Impact · against what's priced in
Kraig Biocraft has demonstrated a critical shift from experimental to industrial scale by increasing monthly output to 1.3 metric tons. The ability to reliably scale production via the BAM-1 Alpha hybrids significantly derisks the company's business model and provides a clear path toward its 10 metric ton target.
- KBLB+0.80
No priced-in read yet
- In context
The fivefold increase in recombinant spider silk production to 1.3 metric tons per month validates the industrial scalability of the BAM-1 Alpha hybrids, moving the company toward a 10 metric ton monthly goal.
Read from the article alone
